Shares of Seattle-based Dendreon Corp. rose nearly 13 percent on Wednesday after the biotechnology company said it would file a federal application to market Provenge, its lead product designed to ...

SEATTLE - For the first time ever, there's a cancer treatment vaccine on the market, and a Seattle company is behind it. The biotech company Dendreon got approval Thursday from the Food and Drug ...

SEATTLE — The American Cancer Society predicts nearly 200,000 men will be diagnosed with prostate cancer this year. So, it's an important topic all men should be discussing with their doctor, or in ...

First comprehensive assessment of DNA errors that drive advanced prostate cancer SEATTLE — Sept. 26, 2011 — A team of researchers at Fred Hutchinson Cancer Research Center and the University of ...

Seventy-four percent of men treated with a combination of radiation seed implants and external beam radiation therapy for prostate cancer are cured of their disease 15 years following their treatment, ...

SEATTLE – September 20, 2016 – Seattle Cancer Care Alliance (SCCA) has opened a new Prostate Cancer Genetics Clinic at their South Lake Union campus in Seattle. The specialty clinic will serve ...